Strategy lifts Bitcoin holdings to 780,897 BTC after $1B purchase
Strategy added 13,927 Bitcoin for about $1 billion on 13 April 2026, pushing its total holdings to 780,897 BTC after one of its biggest weekly purchases in recent months.
Strategy added 13,927 Bitcoin for about $1 billion on 13 April 2026, pushing its total holdings to 780,897 BTC after one of its biggest weekly purchases in recent months.
Kymera Therapeutics (NASDAQ:KYMR) received U.S. Food and Drug Administration Fast Track designation for its experimental treatment for moderate-to-severe eosinophilic asthma, a move that could accelerate the path to market for the first-in-class oral therapy.
Aeluma (NASDAQ:ALMU), a pioneer in the development of high-performance optoelectronic devices, announced on April 13, 2026, that it has been awarded more than $4 million in new U.S. government contracts.
Perella Weinberg Partners (NASDAQ:PWP) has entered into a definitive agreement to acquire Gleacher Shacklock, a prominent London-based independent advisory firm.
Lazard (NYSE:LAZ) reported preliminary assets under management (AUM) of approximately $259.2 billion as of March 31, 2026.
Eli Lilly and Company (NYSE:LLY) announced Monday that its Phase 3 BRUIN CLL-322 trial achieved its primary endpoint, demonstrating that the addition of Jaypirca (pirtobrutinib) to a standard regimen of venetoclax and rituximab significantly extended the time patients lived without their disease worsening.
Somnigroup International (NYSE:SGI) reached an agreement to acquire Leggett & Platt (NYSE:LEG) in an all-stock transaction valued at approximately $2.5 billion, a move that unites the world's largest bedding brand owner with its primary component supplier.
Fastenal (NASDAQ:FAST), a global leader in the wholesale distribution of industrial and construction supplies, reported its financial results for the first quarter ended March 31, 2026, today.
Vertiv Holdings (NYSE:VRT), a global provider of critical digital infrastructure and continuity solutions, announced on April 13, 2026, the acquisition of BMarko Structures.
Regeneron Pharmaceuticals (NASDAQ:REGN) and Telix Pharmaceuticals (NASDAQ:TLX) announced a landmark strategic collaboration on April 13, 2026, to co-develop and co-commercialize next-generation radiopharmaceutical therapies (RPTs).
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy
